Labetalol Hydrochloride
- Product NDC
- 55154-2339
- Requested package NDC
- 55154-2339-0
- 11-digit product format
- 551542339
- Labeler code
- 55154
- Product ID
- 55154-2339_9c79527a-b5aa-4f81-9bfc-b557286ce1cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Cardinal Health
- Application
- ANDA207743
- Marketing category
- ANDA
- Marketing start
- 2017-12-05
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55154-2339 | 55154-2339-0 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207743-001 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | |
| A207743-002 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | RS | 2017-09-19 |
| A207743-003 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207743-001 | AB |
| A207743-002 | AB |
| A207743-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | RS | 2017-09-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-002 | LABETALOL HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2017-09-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-003 | LABETALOL HYDROCHLORIDE | 300MG | TABLET / ORAL | AB | 2017-09-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207743-001 | LABETALOL HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2017-09-19 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207743-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207743-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207743-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207743-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207743-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207743-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207743-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207743-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207743-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207743-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207743-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207743-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207743-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207743-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207743-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207743-001 | AB | 1 | 1e350fbaab3a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | BluePoint Laboratories Inc. | 63ede355-42ec-4c52-a941-51e5f6b35ed6 | 2026-06-08 | Warnings, Adverse reactions | 207743 ANDA207743 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 9c3bb751-c425-43ff-b530-2460b568b689 | 2026-06-05 | Warnings, Adverse reactions | 207743 ANDA207743 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 5942a5a8-c3c1-4ecb-921e-9bc92393bdf8 | 2026-03-02 | Warnings, Adverse reactions | 207743 ANDA207743 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cardinal Health 107, LLC | 63db5b00-e864-4b2d-84f2-00bf35211b9b | 2025-04-21 | Warnings, Adverse reactions | 207743 ANDA207743 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | American Health Packaging | 3004aa59-288c-4971-b77b-78789715ef5a | 2024-12-30 | Warnings, Adverse reactions | 207743 ANDA207743 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Lifesciences Limited | a3c0cc1e-1c01-4009-afdc-d35a66546aec | 2024-11-30 | 207743 ANDA207743 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55154-2339-0 | 55154233900 | 10 BLISTER PACK in 1 BAG (55154-2339-0) > 1 TABLET, FILM COATED in 1 BLISTER PACK | 10 blister pack | 2017-12-05 | 0000-00-00 | No | No | Current |